Diffusion Breast MRI: Current Standard and Emerging Techniques

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Jul 26

PMID 35880168

Authors

Ashley M Mendez

Lauren K Fang

Claire H Meriwether

Summer J Batasin

Stephane Loubrie

Ana E Rodriguez-Soto

Rebecca A Rakow-Penner

Affiliations

Soon will be listed here.

Abstract

The role of diffusion weighted imaging (DWI) as a biomarker has been the subject of active investigation in the field of breast radiology. By quantifying the random motion of water within a voxel of tissue, DWI provides indirect metrics that reveal cellularity and architectural features. Studies show that data obtained from DWI may provide information related to the characterization, prognosis, and treatment response of breast cancer. The incorporation of DWI in breast imaging demonstrates its potential to serve as a non-invasive tool to help guide diagnosis and treatment. In this review, current technical literature of diffusion-weighted breast imaging will be discussed, in addition to clinical applications, advanced techniques, and emerging use in the field of radiomics.

Citing Articles

Exploratory high b value diffusion-weighted MR for quantitative differentiation of ileocecal inflammatory conditions and tumors.

Yu H, Hai Y, Lu J Insights Imaging. 2025; 16(1):41.

PMID: 39962029 PMC: 11833009. DOI: 10.1186/s13244-025-01916-8.

Enhanced preoperative prediction of breast lesion pathology, prognostic biomarkers, and molecular subtypes using multiple models diffusion-weighted MR imaging.

He L, Li F, Qin Y, Li Y, Hu Q, Liu Z Sci Rep. 2025; 15(1):4704.

PMID: 39922806 PMC: 11807203. DOI: 10.1038/s41598-024-81713-3.

Prediction of isocitrate dehydrogenase mutation status in WHO grade II glioma by diffusion kurtosis imaging.

Wu W, Zhang H Pol J Radiol. 2025; 89():e566-e572.

PMID: 39850400 PMC: 11756366. DOI: 10.5114/pjr/195521.

Diffusion weighted imaging for improving the diagnostic performance of screening breast MRI: impact of apparent diffusion coefficient quantitation methods and cutoffs.

Biswas D, Hippe D, Winter A, Li I, Rahbar H, Partridge S Front Oncol. 2025; 14:1437506.

PMID: 39759131 PMC: 11695236. DOI: 10.3389/fonc.2024.1437506.

Quantitative characterization of breast lesions and normal fibroglandular tissue using compartmentalized diffusion-weighted model: comparison of intravoxel incoherent motion and restriction spectrum imaging.

He L, Qin Y, Hu Q, Liu Z, Zhang Y, Ai T Breast Cancer Res. 2024; 26(1):71.

PMID: 38658999 PMC: 11044413. DOI: 10.1186/s13058-024-01828-3.

References

Geach R, JONES L, Harding S, Marshall A, Taylor-Phillips S, McKeown-Keegan S . The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis. Clin Radiol. 2020; 76(2):154.e11-154.e22. DOI: 10.1016/j.crad.2020.08.032. View

Ozal S, Inci E, Akdogan Gemici A, Turgut H, Cikot M, Karabulut M . Can 3.0 Tesla diffusion tensor Imaging parameters be prognostic indicators in breast cancer?. Clin Imaging. 2018; 51:240-247. DOI: 10.1016/j.clinimag.2018.03.022. View

Pinker K, Moy L, Sutton E, Mann R, Weber M, Thakur S . Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging. Invest Radiol. 2018; 53(10):587-595. PMC: 6123254. DOI: 10.1097/RLI.0000000000000465. View

Shukla-Dave A, Obuchowski N, Chenevert T, Jambawalikar S, Schwartz L, Malyarenko D . Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2018; 49(7):e101-e121. PMC: 6526078. DOI: 10.1002/jmri.26518. View

Wiederer J, Pazahr S, Leo C, Nanz D, Boss A . Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. MAGMA. 2013; 27(2):185-93. DOI: 10.1007/s10334-013-0400-9. View

Plaza M, Morris E, Thakur S . Diffusion tensor imaging in the normal breast: influences of fibroglandular tissue composition and background parenchymal enhancement. Clin Imaging. 2016; 40(3):506-11. PMC: 4853756. DOI: 10.1016/j.clinimag.2015.12.001. View

Camps-Herrero J . Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role. BJR Open. 2020; 1(1):20180049. PMC: 7592470. DOI: 10.1259/bjro.20180049. View

Partridge S, Zhang Z, Newitt D, Gibbs J, Chenevert T, Rosen M . Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018; 289(3):618-627. PMC: 6283325. DOI: 10.1148/radiol.2018180273. View

Panzironi G, Moffa G, Galati F, Marzocca F, Rizzo V, Pediconi F . Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner. Breast Cancer Res Treat. 2020; 181(1):53-60. DOI: 10.1007/s10549-020-05592-8. View

10.

Sorace A, Wu C, Barnes S, Jarrett A, Avery S, Patt D . Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting. J Magn Reson Imaging. 2018; . PMC: 6151298. DOI: 10.1002/jmri.26011. View

11.

Sun X, He B, Luo X, Li Y, Cao J, Wang J . Preliminary Study on Molecular Subtypes of Breast Cancer Based on Magnetic Resonance Imaging Texture Analysis. J Comput Assist Tomogr. 2018; 42(4):531-535. DOI: 10.1097/RCT.0000000000000738. View

12.

Tsushima Y, Takahashi-Taketomi A, Endo K . Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging. 2009; 30(2):249-55. DOI: 10.1002/jmri.21854. View

13.

Sjaastad Andreassen M, Rodriguez-Soto A, Conlin C, Vidic I, Seibert T, Wallace A . Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model. Clin Cancer Res. 2020; 27(4):1094-1104. PMC: 8174004. DOI: 10.1158/1078-0432.CCR-20-2017. View

14.

Suo S, Lin N, Wang H, Zhang L, Wang R, Zhang S . Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 tesla: Comparison of different curve-fitting methods. J Magn Reson Imaging. 2014; 42(2):362-70. DOI: 10.1002/jmri.24799. View

15.

Pereira F, Martins G, Figueiredo E, Domingues M, Domingues R, Barbosa da Fonseca L . Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol. 2009; 193(4):1030-5. DOI: 10.2214/AJR.09.2522. View

16.

Horvat J, Bernard-Davila B, Helbich T, Zhang M, Morris E, Thakur S . Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer. J Magn Reson Imaging. 2019; 50(3):836-846. PMC: 6767396. DOI: 10.1002/jmri.26697. View

17.

Kawashima H, Miyati T, Ohno N, Ohno M, Inokuchi M, Ikeda H . Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Acad Radiol. 2017; 24(12):1575-1581. DOI: 10.1016/j.acra.2017.06.016. View

18.

Wang Q, Guo Y, Zhang J, Wang Z, Huang M, Zhang Y . Contribution of IVIM to Conventional Dynamic Contrast-Enhanced and Diffusion-Weighted MRI in Differentiating Benign from Malignant Breast Masses. Breast Care (Basel). 2016; 11(4):254-258. PMC: 5040879. DOI: 10.1159/000447765. View

19.

Gu Y, Pan S, Ren J, Yang Z, Jiang G . Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis. Clin Breast Cancer. 2017; 17(4):245-255. DOI: 10.1016/j.clbc.2016.12.010. View

20.

Kim J, Suh H, Kang H, Shin J, Choo K, Nam K . Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status. Breast Cancer Res Treat. 2016; 157(1):31-40. DOI: 10.1007/s10549-016-3793-0. View